INFORMACIÓN DE FÁRMACOS USADOS:
|
|
|
FÁRMACO 1:
|
|
|
|
Experimental |
|
parsaclisib |
|
|
|
parsaclisib| |
|
INCB050465 |
|
Comprimido* |
|
Treatment will continue as long as the regimen is |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
FÁRMACO 2:
|
|
|
|
Experimental |
|
parsaclisib |
|
|
|
parsaclisib| |
|
INCB050465 |
|
Comprimido* |
|
Treatment will continue as long as the regimen is |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
FÁRMACO 3:
|
|
|
|
Experimental |
|
parsaclisib |
|
|
|
parsaclisib| |
|
INCB050465 |
|
Comprimido* |
|
Treatment will continue as long as the regimen is |
Contenido del fármaco
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
No
|
|
INFORMACIÓN DE PLACEBOS USADOS:
|
|
No hay placebos asignados al ensayo |